Craig Butt

Identifying the unknown PFAS profile in firefighting foams/AFFF

Sep 17, 2021 | Blogs, Environmental / Industrial | 0 comments

Read time: 2 minutes

According to a recent study from Harvard University, the US EPA, and NIEHS, traditional targeted analysis techniques poorly characterize the PFAS composition of contemporary PFAS-based firefighting foams, know as aqueous film-forming foams (AFFF). Using the EPA 533 PFAS drinking water method for the analyte list, the researchers found that targeted mass spectrometry methods accounted for <1% of organic fluorine content. This is important because it demonstrates that targeted analysis methods miss nearly all the PFAS compounds in modern AFFF mixtures, thus underestimating the risk to human health and the environment.

In the second episode of PFAS Fireside chats, the lead author, Bridger Ruyle, joined me to discuss the study’s main findings and implications. Bridger is a PhD student in Environmental Science and Engineering at the Harvard John A. Paulson School of Engineering and Applied Science.

The study examined both legacy and modern commercial AFFF mixtures. AFFF are used to combat petroleum-based fires by creating a barrier between the fire and air, and they are they used extensively at airports and by the military around the globe.

If targeted analytical methods don’t adequately capture all the PFAS compounds in a sample, how did the researchers know what they were missing? First, the researchers used techniques such as “extractable organofluorine (EOF)” to quantify the total potential PFAS compounds in the AFFF mixtures. That is how they showed their targeted methods were missing a substantial portion of the PFAS. Next, they used high-resolution accurate mass spectrometry to identify the unknown PFAS.

So, what’s in these modern AFFF mixtures? It turns out that >90% of the PFAS compounds are 6:2 fluorotelomer-based compounds. While the exact fate of these isn’t well understood, they could potentially degrade to very persistent PFAS compounds, several of which are covered by various state and federal regulations.

The study focused on commercial AFFF mixtures, but what does it look like in the real-world environment where AFFF releases have impacted the surface and groundwater? Bridger and his colleagues addressed that question in a follow-up paper, and perhaps we will talk about it in a future episode of PFAS Fireside chats.

*This content does not constitute legal advice. You should consult counsel to assure your procedures comply with applicable law and that it meets your needs.

RUO-MKT-18-13829-A

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

Craig Butt

Craig has worked in the mass spectrometry industry for over 20 years and has been with SCIEX since 2016. As a senior product application specialist, he works with customers to understand their targeted screening workflows and provide solutions using high-resolution accurate mass spectrometry technologies.

0 Comments